Coronavirus survivors may carry disease-resistant antibodies in their plasma that could be used to treat others currently battling the disease.
The COVID-19 Convalescent Plasma Pittsburgh Project (C2P3) — a collaboration between AHN and other regional health providers — is seeking Coronavirus survivors to get screened and see if they’re eligible to donate plasma.
If you’ve previously tested positive for Coronavirus and are no longer showing symptoms contact the AHN Convalescent Plasma Donor Team at 412-858-C2P3 or C2P3@ahn.org to learn more about screening and donation.
Thank you for your interest in donating plasma for use in treating COVID-19 patients! Before you can donate, you will be required to undergo screening for eligibility. There are three steps in this screening process, and our AHN Convalescent Plasma Donor Team will guide you every step of the way.
Our goal is to make this screening process as easy, fast and safe as possible for you – in fact, it’s as simple as A, B, C, Go!
It’s a multi-step process. Here’s what you can expect:
Yes. You do not need to be an AHN patient in order to donate to the COVID-19 Convalescent Plasma Pittsburgh Project.
The process is similar to giving blood. Your whole blood is drawn and the plasma is separated. Then, your red blood cells are returned to your body along with a saline solution that helps you generate new plasma to replace the plasma that has been removed.
No, AHN will cover cost implications of plasma donation testing and services for any eligible donor, regardless of insurer or where you typically go for care.
Yes, you can donate every 7 days.
By donating through AHN, it’s guaranteed that your plasma will stay local and go to someone in need in your community.